These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19047401)

  • 1. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.
    Arenas-Gamboa AM; Ficht TA; Kahl-McDonagh MM; Gomez G; Rice-Ficht AC
    Infect Immun; 2009 Feb; 77(2):877-84. PubMed ID: 19047401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
    Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).
    Miranda KL; Dorneles EM; Pauletti RB; Poester FP; Lage AP
    Vaccine; 2015 Jan; 33(4):507-11. PubMed ID: 25498211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
    de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
    Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheres.
    Arenas-Gamboa AM; Ficht TA; Davis DS; Elzer PH; Wong-Gonzalez A; Rice-Ficht AC
    J Wildl Dis; 2009 Jan; 45(1):165-73. PubMed ID: 19204345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice.
    Lalsiamthara J; Kaur G; Gogia N; Ali SA; Goswami TK; Chaudhuri P
    Biologicals; 2020 Jan; 63():62-67. PubMed ID: 31843357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.
    Yang X; Thornburg T; Walters N; Pascual DW
    Vaccine; 2010 Jan; 28(4):1069-74. PubMed ID: 19914192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL; Cho Y; Park S; Kim K; Hahn TW
    Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping.
    Miranda KL; Poester FP; Minharro S; Dorneles EM; Stynen AP; Lage AP
    Vaccine; 2013 Jun; 31(29):3014-8. PubMed ID: 23664986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
    Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K
    J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
    Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
    Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NOD-
    Khalaf OH; Chaki SP; Garcia-Gonzalez DG; Ficht TA; Arenas-Gamboa AM
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.
    Arenas-Gamboa AM; Ficht TA; Kahl-McDonagh MM; Rice-Ficht AC
    Infect Immun; 2008 Jun; 76(6):2448-55. PubMed ID: 18362129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against infection in mice vaccinated with a Brucella abortus mutant.
    Boschiroli ML; Cravero SL; Arese AI; Campos E; Rossetti OL
    Infect Immun; 1997 Feb; 65(2):798-800. PubMed ID: 9009345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.